NCT02702895View on ClinicalTrials.gov

Assessment of ASPIRE and HOPE Adherence

CompletedOBSERVATIONAL
Enrollment

302

Participants

Timeline

Start Date

June 13, 2016

Primary Completion Date

December 19, 2018

Study Completion Date

December 19, 2019

Conditions
HIV Prevention
Interventions
BEHAVIORAL

In-depth Interview (IDIs) or Focus Group Discussion (FGD)

Trial Locations (7)

Unknown

Malawi Clinical Research Site, Lilongwe

Botha's Hill Clinical Research Site, Durban

CAPRISA eThekwini Clinical Research Site, Durban

Wits Reproductive Health and HIV Institute Clinical Research Site, Johannesburg

Makerere University - Johns Hopkins University Research Collaboration Clinical Research Site, Kampala

Spilhaus Clinical Research Site, Harare

Zengeza Clinical Research Site, Harare

Sponsors
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Microbicide Trials Network

NETWORK

NCT02702895 - Assessment of ASPIRE and HOPE Adherence | Biotech Hunter | Biotech Hunter